H. Luraschi

Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study

J. Budzik, T. Pascart, C. Godart, 2017, Arthritis Research & Therapy.

Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study.

F. Becce, Hyon K. Choi, J. Budzik, 2021, Seminars in arthritis and rheumatism.

Efficacy in current practice of switching between anti-tumour necrosis factor- α agents in spondyloarthropathies.

J. Salleron, R. Flipo, B. Duquesnoy, 2011, Rheumatology.

Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study

J. Budzik, T. Pascart, C. Godart, 2018, Arthritis Research & Therapy.

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial.

J. Budzik, S. Ottaviani, P. Richette, 2023, The Lancet. Rheumatology.

The lack of association between the burden of monosodium urate crystals assessed with dual-energy computed tomography or ultrasonography with cardiovascular risk in the commonly high-risk gout patient

J. Budzik, T. Pascart, C. Godart, 2018, Arthritis Research & Therapy.